Market Overview

UPDATE: Sterne Agee Downgrades Crocs on Raised Concerns, Lowered Estimates

Related CROX
Death Cross Stocks - The Coca-Cola Company, Crocs, Inc. & More
Crocs (CROX) is Oversold: Can It Recover? - Tale of the Tape

In a report published Thursday, Sterne Agee analyst Sam Poser downgraded Crocs (NASDAQ: CROX) from Neutral to Underperform, and named a $10.00 price target.

In the report, Sterne Agee noted, “Vacate positions in CROX: There is a global senior leadership void. 3 of 5 regions have no director. CROX is selling Crosslite products to on terms that may not be at arms' length. Lowering '13/'14 EPS estimates from $1.01/ $1.33 to $0.99/$1.20.”

Crocs closed on Wednesday at $14.01.

Latest Ratings for CROX

Oct 2014WunderlichInitiates Coverage onBuy
Sep 2014Buckingham ResearchDowngradesBuyNeutral
May 2014CL KingUpgradesNeutralStrong Buy

View More Analyst Ratings for CROX
View the Latest Analyst Ratings

Posted-In: Sam Poser Sterne AgeeAnalyst Color Downgrades Analyst Ratings


Related Articles (CROX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters